-transparent.png){kind=logo}
Platelet monoamine oxidase (MAO) activity was significantly lower among 21 chronic schizophrenic patients, 19 of whom were receiving stable doses of antipsychotic medication, than among 16 control subjects. Poor ego functioning and poor outcome were significantly correlated with low MAO activity; current dose of major tranquilizer was negatively but not significantly correlated. The degree of psychopathology, rather than presence or absence of specific symptom constellations, was the significant characteristic of patients with low enzyme levels. This finding is in accordance with those of earlier studies of schizophrenic patients as well as with recent findings in nonschizophrenic samples.
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
October 1985,
Indian journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
August 1981,
Acta psychiatrica Scandinavica,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
November 1980,
The American journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
June 1983,
The American journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
October 1990,
Indian journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
August 1982,
Psychiatry research,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
June 1980,
The American journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
October 1977,
The American journal of psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
February 1980,
Biological psychiatry,
L Bierer, and
J P Docherty, and
J G Young, and
E Giller, and
D Cohen
October 1979,
The American journal of psychiatry,
